Analysts: Facebook Will Continue to Rise and 3 Other Research Notes to Read Through
Facebook (NASDAQ:FB): Jefferies has raised its price target for Facebook’s shares to $60 from $37, and has increased its estimates for Facebook, citing the company’s “promising” new ad products. The firm sees room for further margin expansion at Facebook as the company monetizes its 1.15 billion user base, and has kept a Buy rating on Facebook’s stock.
Morgan Stanley (NYSE:MS): Credit Suisse has lowered Morgan Stanley’s third-quarter earnings per share estimate to 41 cents from 46 cents versus consensus of 49 cents, due to weaker-than-expected fixed-income contribution and increased litigation costs. Morgan Stanley’s shares are Neutral rated with a $26 price target.
Ralph Lauren (NYSE:RL): Cowen sees recent weakness in Ralph Lauren as a buying opportunity, and the firm noted that its survey data is extremely positive for the Ralph Lauren brand long term. Ralph Lauren’s shares are Outperform rated with a $204 price target.
Stryker Corp. (NYSE:SYK): Wells Fargo thinks that Stryker’s deal to acquire MAKO Surgical could create sales and cost synergies for Stryker but believes that potential integration issues represent the most significant risk for Stryker. The firm has maintained an Outperform rating on Stryker’s shares.
Don’t Miss: Wall Street ‘Likes’ Facebook: Shares Top $50